[29V08-am] がん②

Mon. Mar 29, 2021 10:24 AM - 12:00 PM [Room V08] Oral Presentation 8 (Online)

座長：佐藤聡（東京理大薬）、小幡徹（愛知学院大薬）

+Add all to schedule

10:24 AM - 10:36 AM

[29V08-am08S] Validation of plasma LRG1 as a diagnostic marker for the primary and recurrence of glioblastoma

○Shohei Kawarada¹, Sho Tamai², Tetsuya Terasaki¹, Nakada Mitsutoshi², Yasuo Uchida¹ (1. Graduate School of Pharmaceutical Sciences, Tohoku University, 2. School of Medicine, Kanazawa University)

10:36 AM - 10:48 AM

[29V08-am09S] Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients

○Sena Ikemoto¹, Fuminori Sakurai¹, Kousuke Takayama¹, Takahiro Okabe⁵, Shinsaku Togo⁶, Issei Sumiyoshi⁶, Hiroyuki Mizuguchi^1,2,3,4 (1. Grad.Sch.Pharm.Osaka Univ, 2. Ctr MEI,Osaka Univ, 3. NIBIOHN, 4. Integrated Frontier Research for Medical Science Division, Institute for OTRI, Osaka Univ, 5. Leading Center for the development and research of cancer medicine, 6. Sch.Med.Juntendo Univ)

10:48 AM - 11:00 AM

[29V08-am10S] In vivo antitumor effects by STAT5b inhibition in a mouse glioblastoma model

○Chiami Moyama¹, Mitsugu Fujita², Shota Ando¹, Hiromi Ii¹, Susumu Nakata¹ (1. Kyoto Pharm Univ., 2. Faculty of Med., Kindai Univ.)

11:00 AM - 11:12 AM

[29V08-am11S] Cancer resistance in naked mole-rats via a dampened inflammatory response

○Shusuke Fujioka^1,2, Kaori Oka², Yoshimi Kawamura^2,1, Yoshihiro Komohara², Takeshi Chujo², Yuki Yamamura², Yuki Oiwa², Yoichi Sutoh³, Shohei Komaki³, Natsuko Omamiuda², Tomoko Sakurai⁵, Shimizu Atsushi³, Hideo Bono⁴, Kazuhito Tomizawa², Takuya ¥amamoto⁵, Yasuhiro Yamada⁶, Hiroyuki Oshimi², Kyoko Miura^2,1 (1. Grad. Sch. Medicine., Hokkaido Univ., 2. Grad. Sch. Life Sci., Kumamoto Univ., 3. Iwate Tohoku Medical Megabank Organization, 4. Grad. Sch. Integrated Life Sci., Hiroshima Univ., 5. CiRA, Kyoto Univ., 6. Institute of Medical Sci., University of Tokyo)

11:12 AM - 11:24 AM

[29V08-am12S] High PKCλ expression is required for asymmetric cell division of ALDH1A3-positive breast cancer stem cell

○Shoma Tamori¹, Yuka Nozaki¹, Hitomi Motomura¹, Chotaro Onaga¹, Ayaka Ozaki¹, Kazunori Sasaki², Shigeo Ohno^2,3, Kazunori Akimoto¹ (1. Pharm., Tokyo Univ. Sci., 2. Yokohama City Univ. School of Med., 3. Juntendo Univ. School of Med.)

11:24 AM - 11:36 AM

[29V08-am13S] Inverse correlation between PKCλ and GATA4 at protein level indicates poorer clinical outcomes in TNBC patients

○Ayaka Ozaki¹, Shoma Tamori¹, Kotaro Imaoka¹, Junzo Yamaguchi², Yoshikazu Higami¹, Kazunori Akimoto¹ (1. Pharm., Tokyo. Univ. of Sci., 2. Breast surgery, Fukuoka Seisyukai Hospital)

11:36 AM - 11:48 AM

[29V08-am14S] High SLC20A1 Expression is Associated with Poor Prognoses in Claudin-low and Basal-like Breast Cancers

○Chotaro Onaga¹, Shoma Tamori¹, Hitomi Motomura¹, Ayaka Ozaki¹, Chika Matsuda¹, Izumi Matsuoka¹, Takuma Fujita¹, Yuka Nozaki^1,2, Yasushi Hara³, Yohei Kawano¹, Yohsuke Harada¹, Tsugumichi Sato¹, Yasunari Mano¹, Keiko Sato⁴, Kazunori Akimoto¹ (1. Pharm., Tokyo Univ. Sci., 2. National Cancer Center, 3. Grad. Sch. Bio. Sci., Tokyo Univ. Sci., 4. Sci. and Tech., Tokyo Univ. Sci.)

11:48 AM - 12:00 PM

[29V08-am15S] Correlation between Glyoxalase 1 and Protein kinase C λ is predictive of poor clinical outcomes in late-stage breast cancer

○Hitomi Motomura¹, Ayaka Ozaki¹, Shoma Tamori¹, Chotaro Onaga¹, Yuka Nozaki¹, Waki Yuko¹, Ryoko Takasawa¹, Kazumi Yoshizawa¹, Yasunari Mano¹, Tsugumichi Sato¹, Kazunori Sasaki⁵, Hitoshi Ishiguro^5,6, Yohei Miyagi³, Yoji Nagashima⁴, Kouji Yamamoto⁵, Sato keiko², Takehisa Hanawa¹, Sei-ichi Tanuma⁷, Shigeo Ohno⁵, Kazunori Akimoto¹ (1. Faculty of Pharmaceutical Sci., Tokyo Univ. of Sci., 2. Faculty of Sci. and Tech., Tokyo Univ. of Sci., 3. Kanagawa Cancer Center Research Inst., 4. Tokyo Women's Med. Univ. Hospital, 5. Yokohama City Univ., Sch. of Medicine, 6. Kanagawa Inst. of Ind. Sci. and Tech., 7. RIST, Tokyo Univ. of Sci.)

Session information